Back to Search
Start Over
RBFOX2 regulated EYA3 isoforms partner with SIX4 or ZBTB1 to control transcription during myogenesis.
- Source :
-
IScience [iScience] 2023 Oct 20; Vol. 26 (11), pp. 108258. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Alternative splicing is a prevalent gene-regulatory mechanism, with over 95% of multi-exon human genes estimated to be alternatively spliced. Here, we describe a tissue-specific, developmentally regulated, highly conserved, and disease-associated alternative splicing event in exon 7 of the eyes absent homolog 3 ( Eya3 ) gene. We discovered that EYA3 expression is vital to the proliferation and differentiation of myoblasts. Genome-wide transcriptomic analysis and mass spectrometry-based proteomic studies identified SIX homeobox 4 (SIX4) and zinc finger and BTB-domain containing 1 (ZBTB1), as major transcription factors that interact with EYA3 to dictate gene expression. EYA3 isoforms differentially regulate transcription, indicating that splicing aids in temporal control of gene expression during muscle cell differentiation. Finally, we identified RNA-binding fox-1 homolog 2 (RBFOX2) as the main regulator of EYA3 splicing. Together, our findings illustrate the interplay between alternative splicing and transcription during myogenesis.<br />Competing Interests: X.H.T.W. is a founding partner of Elex Biotech, a start-up company that develops drug molecules that target ryanodine receptors to treat cardiac arrhythmias. X.H.T.W. is also a consultant to Rocket Pharmaceuticals. The remaining authors declare no competing interests.<br /> (© 2023 The Authors.)
Details
- Language :
- English
- ISSN :
- 2589-0042
- Volume :
- 26
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- IScience
- Publication Type :
- Academic Journal
- Accession number :
- 38026174
- Full Text :
- https://doi.org/10.1016/j.isci.2023.108258